Reversible bilateral sensorineural hearing loss associated with atorvastatin: a case report
Atorvastatin is widely prescribed for hyperlipidemia and is generally well tolerated. Auditory adverse effects are rarely reported, and statin-associated sensorineural hearing loss (SNHL) remains poorly characterized.
Research Communities by Springer Nature17h ago 
